Overview

A Trial of HRS-5817 in Obese Participants

Status:
NOT_YET_RECRUITING
Trial end date:
2027-01-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, PK, Pharmacodynamic and immunogenicity profile of a single dose of HRS-5817 in obese participants
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Atridia Pty Ltd.